Vitamin K, the Silent Supporter
In the realm of aging research, Vitamin K is gaining renewed attention, not just for its role in coagulation, but for its broader implications in vascular health and bone density.
A recent article in The Epoch Times explores how Vitamin K, particularly K2, helps stabilize mitochondrial activity and may influence age-related decline by supporting calcium regulation and supporting arterial elasticity.
While often overshadowed by vitamins D and C, emerging evidence suggests that K deserves a more prominent place in the conversation on healthy aging.
Key Takeaways
- The distinction between K1 (phylloquinone) and K2 (menaquinone) matters—especially for cardiovascular and skeletal health
- Dietary sources like natto, leafy greens, and fermented foods may offer protective benefits
- Supplementation strategies are still under investigation, but the science is promising
As we continue to explore the molecular mechanisms of aging, micronutrients like Vitamin K reminds us that small compounds can have outsized impacts.
In the words of Balchem’s research collaborator,
Prof. Allan Linneberg
— Prof. Allan Linneberg, Balchem’s research collaborator, medical doctor, and director at Bispejerg Hospital, Copenhagen“We are investigating this, and there are many gaps in our understanding. Our group, and others, are currently undertaking large trials, including the InterVitaminK trial, which is set to conclude in 2027.
Discover more about how Vitamin K fuels healthy aging
Want to read more? Click below to read the full article or contact us today to speak with one of our K2 experts.
